Literature DB >> 9741926

DNA-polycation nanospheres as non-viral gene delivery vehicles.

K W Leong1, H Q Mao, V L Truong-Le, K Roy, S M Walsh, J T August.   

Abstract

Nanospheres synthesized by salt-induced complex coacervation of cDNA and polycations such as gelatin and chitosan were evaluated as gene delivery vehicles. DNA-nanospheres in the size range of 200-750 nm could transfect a variety of cell lines. Although the transfection efficiency of the nanospheres was typically lower than that of lipofectamine and calcium phosphate controls in cell culture, the beta-gal expression in muscle of BALB/c mice was higher and more sustained than that achieved by naked DNA and lipofectamine complexes. This gene delivery system has several attractive features: (1) ligands can be conjugated to the nanosphere for targeting or stimulating receptor-mediated endocytosis; (2) lysosomolytic agents can be incorporated to reduce degradation of the DNA in the endosomal and lysosomal compartments; (3) other bioactive agents or multiple plasmids can be co-encapsulated; (4) bioavailability of the DNA can be improved because of protection from serum nuclease degradation by the polymeric matrix; (5) the nanosphere can be lyophilized for storage without loss of bioactivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741926     DOI: 10.1016/s0168-3659(97)00252-6

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  63 in total

1.  Cationic nanomicelles for delivery of plasmids encoding interleukin-4 and interleukin-10 for prevention of autoimmune diabetes in mice.

Authors:  Rhishikesh Mandke; Jagdish Singh
Journal:  Pharm Res       Date:  2011-11-11       Impact factor: 4.200

2.  Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.

Authors:  Jing Chen; Wu-Li Yang; Ge Li; Ji Qian; Jing-Lun Xue; Shou-Kuan Fu; Da-Ru Lu
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

3.  In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system.

Authors:  Guangliang Pan; Mohannad Shawer; Svein Oie; D Robert Lu
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

4.  Cationic, helical polypeptide-based gene delivery for IMR-90 fibroblasts and human embryonic stem cells.

Authors:  Jonathan Yen; Yanfeng Zhang; Nathan P Gabrielson; Lichen Yin; Linna Guan; Isthier Chaudhury; Hua Lu; Fei Wang; Jianjun Cheng
Journal:  Biomater Sci       Date:  2013-07       Impact factor: 6.843

5.  Gene expression in tilapia following oral delivery of chitosan-encapsulated plasmid DNA incorporated into fish feeds.

Authors:  Erwin A Ramos; Jenne Liza V Relucio; Celia Aurora T Torres-Villanueva
Journal:  Mar Biotechnol (NY)       Date:  2005-03-11       Impact factor: 3.619

Review 6.  Design of modular non-viral gene therapy vectors.

Authors:  Laura De Laporte; Jennifer Cruz Rea; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-10-21       Impact factor: 12.479

Review 7.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

8.  Long-term stability of chitosan-based polyplexes.

Authors:  Kristine Romøren; Astrid Aaberge; Gro Smistad; Beate J Thu; Oystein Evensen
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

9.  Gold nanoparticles electroporation enhanced polyplex delivery to mammalian cells.

Authors:  Shuyan Huang; Harshavardhan Deshmukh; Kartik Kumar Rajagopalan; Shengnian Wang
Journal:  Electrophoresis       Date:  2014-07       Impact factor: 3.535

10.  Gene delivery via DNA incorporation within a biomimetic apatite coating.

Authors:  Linh N Luong; Kristen M McFalls; David H Kohn
Journal:  Biomaterials       Date:  2009-09-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.